These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19265119)

  • 1. Lymphocytes with aberrant expression of Fas or Fas ligand attenuate immune bone marrow failure in a mouse model.
    Omokaro SO; Desierto MJ; Eckhaus MA; Ellison FM; Chen J; Young NS
    J Immunol; 2009 Mar; 182(6):3414-22. PubMed ID: 19265119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of perforin-mediated cell apoptosis in murine models of infusion-induced bone marrow failure.
    Sarcon AK; Desierto MJ; Zhou W; Visconte V; Gibellini F; Chen J; Young NS
    Exp Hematol; 2009 Apr; 37(4):477-86. PubMed ID: 19216020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity exhibited by Fas ligand (CD95L) overexpressed on lymphoid cells against Fas+ tumor cells.
    Shimizu M; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
    Cancer Immunol Immunother; 1998 Nov; 47(3):143-8. PubMed ID: 9829839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmunity in mice bearing lprcg: a novel mutant gene.
    Kimura M; Matsuzawa A
    Int Rev Immunol; 1994; 11(3):193-210. PubMed ID: 7930845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant role of Fas ligand-binding but defective Fas receptor (CD95) in lymph node hyperplasia composed of abnormal double-negative T cells.
    Matsuzawa A; Shimizu M; Takeda Y; Nagase H; Sayama K; Kimura M
    Immunology; 2002 Aug; 106(4):470-5. PubMed ID: 12153509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mice deficient in fas ligand (gld) or fas (lpr) show few alterations in granulopoiesis.
    Fecho K; Bentley SA; Cohen PL
    Cell Immunol; 1998 Aug; 188(1):19-32. PubMed ID: 9743554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
    Djamali A; Odorico JS
    Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas and Fas ligand expressed on cells of the immune system, not on the target tissue, control induction of experimental autoimmune uveitis.
    Wahlsten JL; Gitchell HL; Chan CC; Wiggert B; Caspi RR
    J Immunol; 2000 Nov; 165(10):5480-6. PubMed ID: 11067900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas ligand (gld)- and Fas (lpr)-deficient mice do not show alterations in the extravasation or apoptosis of inflammatory neutrophils.
    Fecho K; Cohen PL
    J Leukoc Biol; 1998 Sep; 64(3):373-83. PubMed ID: 9738665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of Fas and the costimulatory molecules B7-1 and B7-2 on peripheral lymphocytes in autoimmune B6/gld mice.
    Weintraub JP; Eisenberg RA; Cohen PL
    J Immunol; 1997 Oct; 159(8):4117-26. PubMed ID: 9379003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders.
    Watanabe D; Suda T; Hashimoto H; Nagata S
    EMBO J; 1995 Jan; 14(1):12-8. PubMed ID: 7530197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular interactions in the lpr and gld models of systemic autoimmunity.
    Sobel ES
    Adv Dent Res; 1996 Apr; 10(1):76-80. PubMed ID: 8934931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal IgG galactosylation and arthritis in MRL-Fas(lpr) or MRL-FasL(gld) mice are under the control of the MRL genetic background.
    Kuroda Y; Nakata M; Nose M; Kojima N; Mizuochi T
    FEBS Lett; 2001 Oct; 507(2):210-4. PubMed ID: 11684100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation in the Fas pathway impairs CD8+ T cell memory.
    Dudani R; Russell M; van Faassen H; Krishnan L; Sad S
    J Immunol; 2008 Mar; 180(5):2933-41. PubMed ID: 18292515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-γ-mediated hematopoietic cell destruction in murine models of immune-mediated bone marrow failure.
    Chen J; Feng X; Desierto MJ; Keyvanfar K; Young NS
    Blood; 2015 Dec; 126(24):2621-31. PubMed ID: 26491068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-restricted lymphoproliferation in autoimmune lpr mice.
    Matsuzawa A; Kimura M; Muraiso T; Kominami R; Katagiri T
    Eur J Immunol; 1991 Jun; 21(6):1535-42. PubMed ID: 2044659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Egr-2 in up-regulation of Fas ligand in normal T cells and aberrant double-negative lpr and gld T cells.
    Mittelstadt PR; Ashwell JD
    J Biol Chem; 1999 Jan; 274(5):3222-7. PubMed ID: 9915863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus.
    Satoh M; Weintraub JP; Yoshida H; Shaheen VM; Richards HB; Shaw M; Reeves WH
    J Immunol; 2000 Jul; 165(2):1036-43. PubMed ID: 10878381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional distinctions between MRL-lpr and MRL-gld lymphocytes. Normal cells reverse the gld but not lpr immunoregulatory defect.
    Ettinger R; Wang JK; Bossu P; Papas K; Sidman CL; Abbas AK; Marshak-Rothstein A
    J Immunol; 1994 Feb; 152(4):1557-68. PubMed ID: 8120369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of death receptor pathway in estradiol-induced T-cell apoptosis in vivo.
    Do Y; Ryu S; Nagarkatti M; Nagarkatti PS
    Toxicol Sci; 2002 Nov; 70(1):63-72. PubMed ID: 12388836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.